Min Peng focuses on domestic A-share capital markets legal practice. As the signing lawyer, he has successfully handled IPO, M&A reorganization, and refinancing projects for numerous companies. With a solid legal foundation and extensive practical experience, he employs a rigorous professional attitude and meticulous logical thinking to efficiently resolve various legal challenges in corporate capital operations, assisting companies in navigating key stages such as listing, financing, and resource integration to achieve value leap.

In particular, through long-term dedication and in-depth research in the pharmaceutical industry, Min Peng has a profound understanding of the business models, technical barriers, and regulatory systems in subsectors such as chemical drugs, biologics, traditional Chinese medicine, CXO, and medical devices. He can accurately identify legal risk points throughout the entire chain of pharmaceutical enterprises, from R&D and production to registration and commercialization. He has been deeply involved in the commercial transactions and daily operations of multiple pharmaceutical companies, providing integrated legal support covering capital operations, drug R&D project initiation, registration and application, compliant production, and commercial operation.